Fifteen-minute consultation:Kawasaki disease: how to distinguish from other febrile illnesses: tricks and tips by Kelly, Alison et al.
                          Kelly, A., Sales, K., Fenton-Jones, M., & Tulloh, R. (2020). Fifteen-
minute consultation: Kawasaki disease: how to distinguish from other
febrile illnesses: tricks and tips. Archives of Disease in Childhood:
Education and Practice Edition. https://doi.org/10.1136/archdischild-
2019-316834
Publisher's PDF, also known as Version of record
License (if available):
CC BY-NC
Link to published version (if available):
10.1136/archdischild-2019-316834
Link to publication record in Explore Bristol Research
PDF-document
This is the final published version of the article (version of record). It first appeared online via BMJ at
https://ep.bmj.com/content/early/2020/01/03/archdischild-2019-316834. Please refer to any applicable terms of
use of the publisher.
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the
published version using the reference above. Full terms of use are available:
http://www.bristol.ac.uk/red/research-policy/pure/user-guides/ebr-terms/
  1Kelly A, et al. Arch Dis Child Educ Pract Ed 2020;0:1–6. doi:10.1136/edpract-2019-316834
Best practice and FiFteen- minute consultations
Fifteen- minute consultation: 
Kawasaki disease: how to 
distinguish from other febrile 
illnesses: tricks and tips
alison Kelly,1 Katie sales,2 mary Fenton- Jones,2 robert tulloh   3
1Paediatric Rheumatology, 
Bristol Royal Hospital for 
Children, Bristol, UK
2Bristol Royal Hospital for 
Children, Bristol, UK
3Paediatric Cardiology, Bristol 
Royal Hospital For Children, 
Bristol, UK
Correspondence to
Dr Alison Kelly, Paediatric 
Rheumatology, Bristol Royal 
Hospital for Children, Bristol 
BS2 8BJ, UK;  Alison. Kelly@ 
UHBristol. nhs. uk
Received 13 March 2019
Revised 8 July 2019
Accepted 16 August 2019
To cite: Kelly A, Sales K, 
Fenton- Jones M, et al. 
Arch Dis Child Educ 
Pract Ed Epub ahead of 
print: [please include Day 
Month Year]. doi:10.1136/
edpract-2019-316834
© Author(s) (or their 
employer(s)) 2020. Re- use 
permitted under CC BY- NC. No 
commercial re- use. See rights 
and permissions. Published 
by BMJ.
Box 1 Clinical diagnosis of Kawasaki 
disease
Fever for 5 days or more, plus four of the 
following five criteria (NB: can be diagnosed 
at 4 days if all five criteria present, or 
incomplete with fewer criteria):
 ► Red rash (any type of rash and often from 
day 1, but may disappear).
 ► Red conjunctival injection (not purulent or 
sticky).
 ► Red lips and mouth, cracked dry lips.
 ► Red hands and feet (peeling comes 
late after 10 days—too late to prevent 
aneurysms).
 ► Lymphadenopathy (typically a single large 
lymph node in the neck).
AbstrAct
Kawasaki disease (KD) is challenging to diagnose 
because there is no specific laboratory test and 
the presentation is often similar to common 
childhood infections. We highlight some of those 
KD diagnostic challenges. KD, a self- limiting 
vasculitis, can cause coronary artery aneurysms. 
The aim is to optimise management during the 
acute febrile illness to try and prevent these 
because a giant coronary artery aneurysm is 
devastating enough without thinking that it 
might have been prevented. The conundrum 
for acute paediatricians is which clinical features 
best distinguish the febrile child with possible 
KD, needing intravenous immunoglobulin, from 
the many other children with febrile illnesses.
bAckground
Kawasaki disease (KD), a self- limiting 
systemic vasculitis, remains of unknown 
aetiology and can cause irreversible coro-
nary artery aneurysms (CAAs). In the 
absence of a pathognomonic test, diag-
nosis relies on the clinical presentation.1 
The diagnosis is made in the presence 
of prolonged fever of 5 days or more 
combined with four of the five clinical 
criteria (see box 1). With fewer than four 
criteria present, the diagnosis of incom-
plete KD is considered taking into account 
laboratory and echocardiographic results. 
It is becoming more common, with inci-
dence doubling every 10 years.2 Now 
around 300 children have KD each year 
in the UK (about 10 per 100 000 children 
per year under 5) and may have a lifetime 
of consequences if not treated promptly.3
The decision of when to give intrave-
nous immunoglobulin (IVIG) relies on 
clinical experience and skilled decision 
making, taking into account which clin-
ical features fit with a diagnosis of KD. 
One gram of IVIG is derived from the 
combined plasma of >1000 donors.4 
Donors are screened for known infec-
tions, for example, hepatitis B; however, 
there remains a theoretical risk of infec-
tions, such as those yet to be discovered. 
IVIG side effects include fever, headache, 
vomiting, joint pain, aseptic meningitis, 
and very rarely a severe allergic reac-
tion. Overdiagnosis of KD has recently 
been reported in the USA.5 The challenge 
faced by acute general paediatricians is to 
prevent CAAs while not overdiagnosing.
conundrums when diAgnosing 
kd
the child with features that resemble an 
infection but also fulfils some criteria for kd
A 4- year- old child is reviewed on the 
acute ward round having presented over-
night to the emergency department (ED). 
The fever has been present for 4 days 
with cervical lymphadenopathy, a red 
oropharynx and rash. Antibiotics have not 
been started. The ED doctor has written 
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Box 2 Other recognised findings in Kawasaki 
disease
 ► Extreme irritability.
 ► Aseptic meningitis.
 ► Arthralgia and arthritis.
 ► Pancarditis.
 ► Pericardial effusions.
 ► Congestive cardiac failure.
 ► Valvular dysfunction.
 ► Coronary artery abnormalities.
 ► Diarrhoea, vomiting and abdominal pain.
 ► Hepatic dysfunction.
 ► Hydrops of the gall bladder.
 ► Erythema and induration at the BCG site.
 ► Testicular swelling.
 ► Anterior uveitis.
 ► Perineal erythema and desquamation.
Box 3 Results suggesting severe Kawasaki disease
 ► High white cell count.
 ► Very high C reactive protein.
 ► Low serum sodium.
 ► Low albumin.
 ► Low haemoglobin.
 ► Low platelet count.
 ► High aspartate transaminase.
 ► High bilirubin.
 ► High ferritin (NB: very high ferritin, >10 000 μg/L, 
indicates haemophagocytic lymphocytic histiocytosis).
Box 4 Routine investigations in suspected 
Kawasaki disease
 ► Blood
 – Inflammatory markers (erythrocyte sedimentation rate 
and C reactive protein).
 – Liver function tests.
 – Full blood count, urea and electrolytes, ferritin, clotting 
and blood cultures.
 – Antistreptolysin titre (ASOT) and anti- DNAse B, D- 
dimer, mycoplasma serology, autoimmune profile, 
ANCA, C3 and C4, and save serum.
 – Viral serology/PCR.
 ► Urine dip and. urine microscopy, culture and sensitivity
 ► Throat swab (bacterial and viral).
 ► Echocardiogram
 – At diagnosis, 2 weeks and 6 weeks.
 ► ECG
but because only three of the five criteria were present 
IVIG was not started.
This may be an acute infection, such as a beta- 
haemolytic streptococcal or adenoviral tonsillitis. 
However, should IVIG be given now? It would seem 
sensible in many similar cases of possible KD to try 
intravenous broad- spectrum antibiotics for potential 
bacterial illness for 24 hours while observing, and to 
avoid exposure to IVIG unless fever and features of 
KD continue. Viral throat swabs may help to iden-
tify a pathogen, but with the aetiology of KD being 
unknown there also remains the possibility that KD 
may be triggered by, or coexist with, an infection. A 
detailed history should ask specifically for KD criteria, 
since they often occur sequentially. Photographs taken 
by parents earlier in the illness may also help to confirm 
a diagnosis. Considering KD early in the admission is 
important. Not thinking of KD may lead to delayed 
treatment or missed cases.
Diagnosis may be helped if a typical feature of KD is 
present, such as irritability. KD can cause a wide variety 
of non- specific symptoms and signs, for example 
gastrointestinal symptoms, in addition to the criteria. 
Some findings which can help to suggest KD include 
reactivation of BCG immunisation site, irritability, 
perineal redness, meningeal irritation and arthritis (see 
box 2). KD irritability may persist despite antipyretics 
and is extreme compared with many other illnesses.
Clearly every febrile child with red oropharynx and 
lymphadenopathy does not require IVIG, and deciding 
on treatment relies entirely on skilled judgement of 
whether clinical features fit with a diagnosis of KD. 
The only pathognomonic test is CAA on echocardio-
gram, which is what early IVIG treatment would hope-
fully prevent.
the persistently febrile very young child
A 4- month- old presented with 3 days of diarrhoea and 
a blanching rash. His parents had not noticed fever 
until vomiting prompted attendance to hospital. On 
arrival he was feverish (38°C), and the following day 
the rash resolved. Investigations show raised C reac-
tive protein (CRP) and negative septic screen. Despite 
ceftriaxone intermittent fevers continue. On day 8 
of fever in hospital, an echocardiogram shows giant 
CAAs. Treatment is started including IVIG, steroids 
due to a lack of response to IVIG, and heparin.
Features of KD such as rash may resolve during the 
illness, and very young children may have incomplete 
KD and few features of KD except persistent fever. 
Very young children are high risk as they are less likely 
to respond to IVIG, are more likely to require steroids 
and are more likely to develop CAAs. Try not to leave 
a very young child without treatment for KD if the 
febrile illness is prolonged. Less than 6 months old is 
a red flag for KD complications; these children have 
the fewest features of KD but develop the worst coro-
nary artery disease. In the UK 39% of infants develop 
coronary artery involvement, highlighting the need to 
recognise KD and treat urgently.3
the febrile child with gastrointestinal symptoms
A 3- year- old is reviewed on the ward. He was admitted 
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Figure 1 Algorithm for management of KD. CAA, coronary artery aneurysm; CRP, C reactive protein; ESR, erythrocyte sedimentation rate; IVIG, 
intravenous immunoglobulin; KD, Kawasaki disease; q.d.s, four times a day.
fever not responding to antipyretics. Investigations 
have shown raised inflammatory markers, low albumin 
and distended gall bladder on abdominal ultrasound. 
His parents report today is day 7 of fever. Extreme 
irritability and cervical lymphadenopathy, along with 
a new finding of injected conjunctivae, are noted on 
review. KD is diagnosed and IVIG given.
A fever unresponsive to antipyretics or dispropor-
tionate irritability can be indicators of KD. Viral- like 
symptoms such as sore throat, abdominal pain, diar-
rhoea or cough are not reassuring because these can 
occur in KD. Features may appear sequentially and 
may not be present together on examination. Children 
with unexplained fever require repeat reviews for any 
developing features of KD. A child not following the 
normal trajectory of illness, in this case not typical for 
viral gastroenteritis, needs to have other conditions, 
such as KD, considered as early as possible. Gallbladder 
distension can occur in KD and raises the possibility 
of abdominal ultrasound being a useful investigation 
when a diagnosis is being considered.
the child treated with iVig then re-presents febrile
A 1- year- old is diagnosed with complete KD and has a 
normal echocardiogram. She becomes afebrile during 
the IVIG and is discharged the following day. She is 
readmitted to hospital 3 days later with a further 
history of fevers at home since discharge. The echocar-
diogram shows small CAAs and she receives a second 
dose of IVIG and steroids.
Children are routinely monitored in hospital following 
treatment for KD to ensure that they do not have recru-
descence of fever, which requires further treatment. 
Observation for at least 48 hours without fever is reas-
suring following treatment. This child has aneurysms 
in keeping with her KD diagnosis. However, in other 
cases if there is a lack of sustained response to IVIG, 
consideration of other diagnoses would be appropriate, 
for example, systemic juvenile idiopathic arthritis, and 
discussion with paediatric rheumatologists is advised as 
steroid therapy might be indicated.
the child who peels or has a retrospective diagnosis of 
kd
A 6- year- old re- presents to ED with peeling fingers 
10 days after resolution of an 8- day febrile illness. 
Her parents read on the internet about KD and are 
concerned that she may need IVIG. Inflammatory 
markers, ECG and echocardiogram are normal.
KD remains one possible differential diagnosis 
retrospectively. However there is no evidence of 
ongoing inflammation and no CAAs, so the child is 
started on low- dose aspirin and an appointment for a 




















Kelly A, et al. Arch Dis Child Educ Pract Ed 2020;0:1–6. doi:10.1136/edpract-2019-3168344
Best practice and Fifteen- minute consultations
Test your knowledge
1. Kawasaki disease is increasingly common. The current incidence per year in the UK in children under 5 years is (single best 
answer):
A. 1 in 100 000.
B. 1 in 50 000.
C. 1 in 30 000.
D. 1 in 10 000.
E. 1 in 1000.






3. The frequency of infants (those under 1 year) having coronary artery involvement in the UK in Kawasaki disease after diagnosis 






4. The correct treatment regimen for acute Kawasaki disease is (multiple answers):
A. 1 g/kg immunoglobulin over 6 hours and repeated the next day.
B. 2 g/kg immunoglobulin over 12 hours plus 7.5 mg aspirin 4 times a day.
C. Immunoglobulin infusion should be  
repeated at 48 hours if there is no resolution of fever.
D. Intravenous methylprednisolone should be added to the initial treatment in children with high- risk features of age <6 months, 
CRP >100, low platelet count and coronary artery dilation already present.
E. Infliximab is commonly given to  
suppress coronary artery aneurysm formation.
5. Transition to adult care is important in all chronic diseases (multiple answers).
A. Kawasaki disease is not chronic, so no transition is needed.
B. All children who have had Kawasaki disease need long- term care.
C. Those who have giant coronary artery aneurysms are at most risk and have to have annual assessment, ongoing 
investigations and transition to adult Kawasaki clinics.
D. Those whose aneurysms have resolved on imaging can be discharged.
E. 3.8% of adults under 50 years old undergoing coronary angiography have aneurysms and ST elevation myocardial 
infarction that are due to previous Kawasaki disease.
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Test your knowledge 
for parents to suggest the diagnosis of KD and cases 
should be reviewed accordingly.
the child reviewed in primary care with 4 days of fever
A 7- year- old is seen in primary care with 4 days of 
fever. A rash on day 2 has resolved and he had a cough 
at the beginning of the illness. His temperature returns 
to normal with paracetamol. He has a red oropharynx, 
runny nose, no tonsillar exudate and no lymphadenop-
athy. The doctor documents absence of other features 
of KD.
This child is approaching day 5 of fever; however, 
this is probably a common upper respiratory tract 
infection. Advice should be given to his family to return 
for medical review in 2 days if his fever continues. If all 
the diagnostic features of complete KD were present, 
it would be acceptable to treat at fewer than 5 days of 
fever.
kd inVestigAtions And scoring systems
Investigations can help to diagnose KD, for example, 
raised CRP and erythrocyte sedimentation rate, despite 
there not being a pathognomonic test. Some patterns 
of results suggest severe KD (see box 3).
Viral tests or throat swabs do not help exclude KD. 
Lumbar puncture may be positive for non- specific 
inflammation (lymphocytes) in KD. Urine may show 
sterile pyuria. Abdominal ultrasound may show a 
swollen gall bladder if performed. Some investigations 
are routine in suspected KD (box 4).
There are scoring systems used in Japan to detect 
those at high risk of not responding to treatment, but 
they are not reliable in the UK.6
when should i use An echocArdiogrAm to 
help me mAke the diAgnosis?
An echocardiogram should be performed on the same 
day as the diagnosis is made. It can help make the diag-
nosis if abnormal, but a normal echocardiogram does 
not exclude KD. If a child presents after resolution of 
the febrile illness and is suspected on history to have 
had KD, they may have the diagnosis confirmed if the 
echocardiogram is abnormal.
The size of the coronary arteries is assessed by Z 
score (the number of SD above average for that sized 
child). A Z score equal to or more than 2.5 at 6 weeks 
is a CAA. If the child has a giant CAA (Z score >10), 
then the early management will be different (see 
figure 1). Some children can have pericardial effusion, 
depressed heart function or valve regurgitation, and so 
it is important to know about this early.
treAtment
It is important that IVIG (2 g/kg over approximately 
12 hours) is given at the earliest opportunity (figure 1). 
Every day’s delay markedly increases the risk of CAA 
formation. High- dose aspirin, as an anti- inflammatory, 
should be given at the same time (7.5 mg/kg 6 hourly) 
until apyrexial for 48 hours. Those children who are 
high risk (as above) should receive intravenous steroids 
in addition (discuss with local expert).
If the fever has settled for 48 hours, then the child 
can be sent home on low- dose aspirin (5 mg/kg each 
day) for its antiplatelet effect. If it does not settle, they 
may need another dose of immunoglobulin, steroids 
considering, and a plan made for a biologic if the fever 
persists, such as infliximab or anakinra. However, all 
these children who are difficult to manage should be 
discussed with an expert in KD.
Follow-up
Children who never had coronary artery involve-
ment can be discharged at 6 months, but those with 
aneurysms are followed lifelong and stay on low- dose 
aspirin, even if they resolved (see figure 1). Those 
under follow- up should be transitioned to adult KD 
clinics and have a risk of major coronary events in the 
future (30% in those with giant aneurysms). Of young 
adults with myocardial ischaemia, 3.8% have been 
found to have CAA on angiography.7
pAtient-speciFic protocols: whAt Are they?
As a result of a patient safety alert issued by NHS 
England 3 years ago, all children with known cardiac 
complications of KD should be issued with a patient- 
specific protocol. This gives a brief summary of the 
child’s complications and what to do in the event of 
acute cardiac symptoms, when they should usually be 
taken direct to a specialist children cardiac surgical 
centre for acute management, such as thrombol-
ysis of the coronary arteries or cardiac catheter lab 
intervention.
Future directions
It is hoped that there will be a diagnostic test in the 
near future. KD often remains a challenging diagnosis 
to make with certainty. Increasing consultation with 
colleagues with expertise in KD may help to inform 
clinical decision making.
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Answers to the multiple choice questions
1. D is true. In Japan, it is now up to 3.2 per 1000 children 
such that the prevalence is over 10%.
2. A, B, D and E are true. KD can cause almost any 
symptom; however, while sterile pyuria does occur, 
dysuria is not reported.
3. E is true. The incidence of coronary artery involvement 
is very high in treated infants. These children often only 
have some of the features of Kawasaki disease and can 
easily be missed due to incomplete Kawasaki disease. 
They have the worst cardiac involvement.
4. B, C and D are true. Infliximab is a good agent for 
treating resistant Kawasaki disease but is only used 
rarely and in resistant cases where immunoglobulin, 
aspirin and intravenous steroids have failed to work.
5. C and E are true. We do not follow up children who have 
never had coronary artery involvement; it would cause 
unnecessary anxiety and there is no evidence that they 
are at risk. Those with severe coronary artery disease 
should be followed very carefully, and 3.8% of adults 
undergoing coronary angiography have artery aneurysms 
due to previous Kawasaki disease.
Robert Tulloh http:// orcid. org/ 0000- 0002- 3180- 6993
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